Clinical Trial Update: Evaluation of Adherence to Cell Cycle Inhibitors Used as Adjuvant Therapy in Patients With Localized Breast Cancer at High Risk of Recurrence.

View source ↗

Summary

Clinical trial update investigating adherence to cell cycle inhibitors as adjuvant therapy in localized high-risk breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• KISQALI (ribociclib)
• VERZENIO (ABEMACICLIB)

Snippet

Sponsor: University Hospital, Grenoble | Conditions: ER+ Breast Cancer, Breast Cancer | Status: NOT_YET_RECRUITING